.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Deloitte
Cantor Fitzgerald
Healthtrust
Cerilliant
Boehringer Ingelheim
Covington
Daiichi Sankyo
UBS

Generated: September 23, 2017

DrugPatentWatch Database Preview

Estrogens, conjugated; meprobamate - Generic Drug Details

« Back to Dashboard

What are the generic sources for estrogens, conjugated; meprobamate and what is the scope of estrogens, conjugated; meprobamate freedom to operate?

Estrogens, conjugated; meprobamate
is the generic ingredient in four branded drugs marketed by Medpointe Pharm Hlc and Wyeth Ayerst, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estrogens, conjugated; meprobamate.

Summary for Generic Name: estrogens, conjugated; meprobamate

Tradenames:4
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list3
Clinical Trials: see list298
Drug Prices:see low prices
DailyMed Link:estrogens, conjugated; meprobamate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc
MILPREM-400
estrogens, conjugated; meprobamate
TABLET;ORAL011045-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
MILPREM-200
estrogens, conjugated; meprobamate
TABLET;ORAL011045-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PMB 400
estrogens, conjugated; meprobamate
TABLET;ORAL010971-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PMB 200
estrogens, conjugated; meprobamate
TABLET;ORAL010971-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: estrogens, conjugated; meprobamate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
PMB 200
estrogens, conjugated; meprobamate
TABLET;ORAL010971-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Wyeth Ayerst
PMB 400
estrogens, conjugated; meprobamate
TABLET;ORAL010971-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
QuintilesIMS
Chinese Patent Office
Dow
Novartis
Citi
Cipla
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot